Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00409435 · ClinicalTrials.gov registry record · Phase 2

A Study of Pyridostigmine in Postural Tachycardia Syndrome

A Phase 2 study of Postural Tachycardia Syndrome, sponsored by Mayo Clinic.

Recruiting
Registry status
Phase 2
Development phase
50
Enrollment target
1
Study location

NCT00409435 is a Phase 2 study of Postural Tachycardia Syndrome that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 80-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00409435, a Phase 2 study of Postural Tachycardia Syndrome, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Phase 2
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.

Conditions Studied

Postural Tachycardia Syndrome

Interventions

  • DRUG Placebo
  • DRUG pyridostigmine

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2006-10
Est. Completion 2027-02
Phase Phase 2

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00409435

The ClinicalTrials.gov registry entry for NCT00409435 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (37% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00409435 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00409435 about?

NCT00409435 is a clinical study titled "A Study of Pyridostigmine in Postural Tachycardia Syndrome". This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.

What is the current status of trial NCT00409435?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2006-10. Estimated completion is 2027-02.

What conditions does trial NCT00409435 study?

This clinical trial studies the following conditions: Postural Tachycardia Syndrome.

What interventions are being tested in trial NCT00409435?

The interventions under investigation include: Placebo (DRUG), pyridostigmine (DRUG).

Who is sponsoring clinical trial NCT00409435?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00409435 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Postural Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Postural Tachycardia Syndrome

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.